Literature DB >> 3631311

Optimal experiment design for nonlinear models subject to large prior uncertainties.

E Walter, L Pronzato.   

Abstract

Classical experiment design generally yields an experiment that depends on the value of the parameters to be estimated, which are, of course, unknown. Assuming that the model parameters belong to a population with known statistics, we propose to take the a priori parameter uncertainty into account by optimizing the mathematical expectation of a functional of the Fisher information matrix. This optimization is performed with a stochastic approximation algorithm that makes robust experiment design almost as simple as classical D-optimal design. The resulting methodology is applied to the choice of measurement times for multiexponential models.

Mesh:

Year:  1987        PMID: 3631311     DOI: 10.1152/ajpregu.1987.253.3.R530

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  7 in total

1.  Robust optimal design for the estimation of hyperparameters in population pharmacokinetics.

Authors:  M Tod; F Mentré; Y Merlé; A Mallet
Journal:  J Pharmacokinet Biopharm       Date:  1998-12

2.  Adaptive optimal design for bridging studies with an application to population pharmacokinetic studies.

Authors:  Lee Kien Foo; Stephen Duffull
Journal:  Pharm Res       Date:  2012-02-14       Impact factor: 4.200

3.  Sample size computations for PK/PD population models.

Authors:  Dongwoo Kang; Janice B Schwartz; Davide Verotta
Journal:  J Pharmacokinet Pharmacodyn       Date:  2005-12       Impact factor: 2.745

4.  Comparison of ED, EID, and API criteria for the robust optimization of sampling times in pharmacokinetics.

Authors:  M Tod; J M Rocchisani
Journal:  J Pharmacokinet Biopharm       Date:  1997-08

5.  Optimal experimental design for predator-prey functional response experiments.

Authors:  Jeff F Zhang; Nikos E Papanikolaou; Theodore Kypraios; Christopher C Drovandi
Journal:  J R Soc Interface       Date:  2018-07       Impact factor: 4.118

6.  Experiment design for nonparametric models based on minimizing Bayes Risk: application to voriconazole¹.

Authors:  David S Bayard; Michael Neely
Journal:  J Pharmacokinet Pharmacodyn       Date:  2016-12-01       Impact factor: 2.745

7.  Limited and optimal sampling strategies for etoposide and etoposide catechol in children with leukemia.

Authors:  John Carl Panetta; Mark Wilkinson; Ching-Hon Pui; Mary V Relling
Journal:  J Pharmacokinet Pharmacodyn       Date:  2002-04       Impact factor: 2.745

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.